iThrive MD

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded GLP-1 medicationCompounded · not FDA-approved

What they publish

iThrive MD publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

48 weeks paid upfront published at $1,755, stated as $146.25 per month with shipping every 28 days; a $1,053 option and a $48.75 per month figure also published (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

States medication ships every 28 days across the 48-week course.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Pricing a full 48-week course rather than a rolling month is honest about how long treatment actually runs — but it also means $1,755 committed before you know whether you tolerate the drug.
• The 28-day shipping cycle means 13 shipments across 48 weeks, not 12.
• Around a fifth to a third of people discontinue GLP-1 treatment early, most often from side effects. That is the risk a 48-week prepayment carries.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Ask what the refund position is if you stop for medical reasons mid-course.
• Consider whether a shorter commitment would let you test tolerability first.
• Ask which pharmacy compounds it and whether it is 503A or 503B.